2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

@article{Mancia20072007GF,
  title={2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).},
  author={G. Mancia and G. De Backer and A. Dominiczak and R. C{\'i}fkov{\'a} and R. Fagard and G. German{\'o} and G. Grassi and A. Heagerty and S. Kjeldsen and S. Laurent and K. Narkiewicz and L. Ruilope and A. Rynkiewicz and R. Schmieder and H. S. Struijker Boudier and A. Zanchetti and A. Vahanian and J. Camm and R. De Caterina and Ver{\'o}nica Dean and K. Dickstein and G. Filippatos and C. Funck-Brentano and I. Hellemans and S. Kristensen and K. Mcgregor and U. Sechtem and S. Silber and M. Tendera and P. Widimsky and J. Zamorano and S. Erdine and W. Kiowski and E. Agabiti-Rosei and E. Ambrosioni and L. Lindholm and A. Manolis and P. Nilsson and J. Redon and H. Struijker‐Boudier and M. Viigimaa and S. Adamopoulos and V. Bertom{\'e}u and D. Clement and C. Farsang and D. Gaita and G. Lip and J. Mallion and E. O’Brien and P. Ponikowski and F. Ruschitzka and J. Tamargo and P. V. van Zwieten and B. Waeber and B. Williams and The task force for the management of arterial hype},
  journal={European heart journal},
  year={2007},
  volume={28 12},
  pages={
          1462-536
        }
}
For several years the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided not to produce their own guidelines on the diagnosis and treatment of hypertension but to endorse the guidelines on hypertension issued by the World Health Organization (WHO) and International Society of Hypertension (ISH)1,2 with some adaptation to reflect the situation in Europe. However, in 2003 the decision was taken to publish ESH/ESC specific guidelines3 based on the fact that… Expand

Paper Mentions

Interventional Clinical Trial
Pioglitazone, a medication of thiazolidinedione group, is capable of triggering the peroxisome proliferator-activated receptors (PPAR-γ). Activation of receptor PPAR-γ regulates… Expand
ConditionsAdverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
InterventionDrug
Management of hypertension in adults: the 2013 French Society of Hypertension guidelines
Developing hypertension guidelines: an evolving process.
  • T. Kotchen
  • Medicine
  • American journal of hypertension
  • 2014
New guidelines of the European society of hypertension
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 1,245 REFERENCES
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
  • G. De Backer, E. Ambrosioni, +18 authors D. Wood
  • Medicine
  • European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
  • 2003
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.
...
1
2
3
4
5
...